These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma. Lv H; Cui A; Sun F; Zhang Y; Li Y; Li L; Lin Z Exp Mol Pathol; 2014 Aug; 97(1):74-80. PubMed ID: 24866365 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer. Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329 [TBL] [Abstract][Full Text] [Related]
4. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery. Wen Y; Wang Q; Zhou C; Yan D; Qiu G; Yang C; Tang H; Peng Z Ann Surg Oncol; 2011 Dec; 18(13):3858-67. PubMed ID: 21442347 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas. Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745 [TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma. Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316 [TBL] [Abstract][Full Text] [Related]
7. An abnormally high expression of ISL-1 represents a potential prognostic factor in gastric cancer. Guo C; Wang W; Shi Q; Chen P; Zhou C Hum Pathol; 2015 Sep; 46(9):1282-9. PubMed ID: 26142548 [TBL] [Abstract][Full Text] [Related]
8. [Expression of transcription factor Sp1 in human gastric cancer tissue and its correlation with prognosis]. Wang LW; Li Q; Hua ZL; Zhou F; Keping X; Daoyan W; Yao J; Ajani J Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):107-11. PubMed ID: 17645844 [TBL] [Abstract][Full Text] [Related]
9. Decreased expression of V-set and immunoglobulin domain containing 1 (VSIG1) is associated with poor prognosis in primary gastric cancer. Chen Y; Pan K; Li S; Xia J; Wang W; Chen J; Zhao J; Lü L; Wang D; Pan Q; Wang Q; Li Y; He J; Li Q J Surg Oncol; 2012 Sep; 106(3):286-93. PubMed ID: 22095633 [TBL] [Abstract][Full Text] [Related]
10. Intratumoral but not peritumoral lymphatic vessel density measured by D2-40 expression predicts poor outcome in gastric cancer--ROC curve analysis to find cut-off point. Donizy P; Rudno-Rudzinska J; Halon A; Dziegala M; Kabarowski J; Frejlich E; Dziegiel P; Kielan W; Matkowski R Anticancer Res; 2014 Jun; 34(6):3113-8. PubMed ID: 24922680 [TBL] [Abstract][Full Text] [Related]
11. CD44(+) CD324(-) expression and prognosis in gastric cancer patients. Cao L; Hu X; Zhang J; Liang P; Zhang Y J Surg Oncol; 2014 Nov; 110(6):727-33. PubMed ID: 24910454 [TBL] [Abstract][Full Text] [Related]
12. KITENIN is associated with tumor progression in human gastric cancer. Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126 [TBL] [Abstract][Full Text] [Related]
13. [Expression of HER-2 and leptin in gastric cancer and their clinical significance]. Geng YT; Qiu JR; Wang R; Su YT; Shu YQ; Yin YM Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):764-9. PubMed ID: 22335909 [TBL] [Abstract][Full Text] [Related]
14. DOK2 as a marker of poor prognosis of patients with gastric adenocarcinoma after curative resection. Miyagaki H; Yamasaki M; Takahashi T; Kurokawa Y; Miyata H; Nakajima K; Takiguchi S; Fujiwara Y; Mori M; Doki Y Ann Surg Oncol; 2012 May; 19(5):1560-7. PubMed ID: 22130622 [TBL] [Abstract][Full Text] [Related]
15. Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry. Wen YG; Wang Q; Zhou CZ; Yan DW; Qiu GQ; Yang C; Tang HM; Peng ZH J Surg Oncol; 2011 Oct; 104(5):516-24. PubMed ID: 21618246 [TBL] [Abstract][Full Text] [Related]
16. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features. Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878 [TBL] [Abstract][Full Text] [Related]
18. Expression of moesin and CD44 is associated with poor prognosis in gastric adenocarcinoma. Jung WY; Kang Y; Lee H; Mok YJ; Kim HK; Kim A; Kim BH Histopathology; 2013 Oct; 63(4):474-81. PubMed ID: 23889297 [TBL] [Abstract][Full Text] [Related]
19. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression. Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of osteopontin expression in human gastric carcinoma. Higashiyama M; Ito T; Tanaka E; Shimada Y Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]